Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 EUR)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 13,886 Less Arrow 3,313 Less Arrow 608
Financial expenses 4,371 Less Arrow 119 Less Arrow 26
Earnings before taxes -54,813 More Arrow -53,597 More Arrow -41,932
EBITDA -52,891 Less Arrow -53,484 More Arrow -41,359
Total assets 151,632 Less Arrow 99,034 More Arrow 142,914
Current assets 144,200 Less Arrow 92,143 More Arrow 138,818
Current liabilities 23,787 Less Arrow 16,742 Less Arrow 11,378
Equity capital 54,178 More Arrow 74,077 More Arrow 123,748
- share capital 4,945 Less Arrow 4,531 Less Arrow 4,129
Employees (average) 144 Less Arrow 116 Less Arrow 82

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 35.7% More Arrow 74.8% More Arrow 86.6%
Turnover per employee 96 Less Arrow 29 Less Arrow 7
Profit as a percentage of turnover -394.7% Less Arrow -1617.8% Less Arrow -6896.7%
Return on assets (ROA) -33.3% Less Arrow -54.0% More Arrow -29.3%
Current ratio 606.2% Less Arrow 550.4% More Arrow 1220.1%
Return on equity (ROE) -101.2% More Arrow -72.4% More Arrow -33.9%
Change turnover 10,841 Less Arrow 2,716 Less Arrow 272
Change turnover % 356% More Arrow 456% Less Arrow 81%
Chg. No. of employees 28 More Arrow 34 Less Arrow 19
Chg. No. of employees % 24% More Arrow 41% Less Arrow 30%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.